A.R.T. Advisors, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 80 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$503,000
+208.6%
33,736
+189.9%
0.02%
+150.0%
Q1 2019$163,000
+44.2%
11,636
-18.8%
0.01%
+66.7%
Q2 2017$113,00014,3370.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders